Serum Sickness: Immune Complex Reaction to Foreign Proteins

Serum sickness is a type III hypersensitivity reaction to heterologous proteins (antivenom, antitoxin, monoclonal antibodies, streptokinase, some vaccines).

Pathophysiology

  • Foreign protein + IgG/IgM → immune complexes → deposit in vessels, joints, kidneys → complement activation (C3a, C5a) → neutrophil recruitment → inflammation.
  • Onset: 7–14 days post-exposure (first exposure); 1–3 days (re-exposure).

Clinical Features

  • Fever, rash (urticaria, morbilliform, purpuric).
  • Arthralgia/arthritis (knees, wrists, ankles).
  • Myalgia, lymphadenopathy.
  • GI: nausea, vomiting, diarrhea.
  • Renal: proteinuria, hematuria, glomerulonephritis (severe).
  • Neurologic: rare (Guillain-Barré-like).

Diagnosis

  • Clinical criteria + exposure history.
  • Labs: low C3/C4, elevated ESR/CRP, immune complexes, proteinuria.

Treatment

  • Mild: Antihistamines, NSAIDs, stop offending agent.
  • Moderate-severe: Prednisone 0.5–1 mg/kg/day ×1–2 weeks, taper.
  • Refractory/life-threatening: Plasmapheresis, IVIG, cyclophosphamide.

Prognosis

Self-limited (1–3 weeks) with treatment. No long-term sequelae typically. Re-exposure risk → premedicate or avoid.

Blood Disorders - Related Articles